-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Scientists have long sought how the symptoms of some diseases are confined to just one tissue, while they are caused by a single defective protein spread throughout the body
Familial partial lipodystrophy type 2 (FPLD2) is a rare disorder that causes diabetes, loss of fat in the extremities, and overdevelopment of muscle, but the defective protein (lamin A) is present in all cells
Scientists at the University of Edinburgh found that mice lacking the protein Tmem120a, which is mainly found in fat cells, developed symptoms similar to FPLD2
Tmem120a belongs to a group of proteins called NETs that help ensure the correct organization and interpretation of the cell's genetic material, which resides in the cell's command center, within the nucleus
They found that Tmem120a plays a key role in normal adipose tissue development and healthy metabolism by boosting the expression of adipose genes and turning off muscle genes in adipose tissue
These effects appear to be due to Tmem120a's ability to release parts of the genome that control fat metabolism from the nuclear edge while simultaneously recruiting muscle genes to the nucleus
When genes are located at the edge of the nucleus, they tend to be turned off, and the scientists found that mislocalization of the gene in mice lacking Tmem120a also occurred in human patients with FPLD2
The study's authors propose that because Tmem120a is predominantly found in adipose tissue, it mediates the adipose-specific defect caused by the defective lamin A previously associated with FPLD2
Studies of the genetic defects that cause metabolic diseases have shown that these defects are associated with many genes, so Tmem120a may be similar by affecting the localization of many genes
The finding could have broader implications for other metabolic diseases, such as diabetes, insulin resistance, glucose intolerance, obesity, as well as muscle disorders and fitness
These symptoms, which were only seen in mice fed a high-calorie diet, were consistent with symptoms of FPLD2, which typically appears later in life and requires careful diet control
This mechanism could explain why some diseases, such as diabetes, are only detected when the body is under stress—such as feeding a high-calorie diet to mice lacking the Tmem120a gene
Defects in the function of other NETs proteins are associated with many human diseases, such as muscular dystrophy, cardiomyopathy, blood and bone diseases, cancer and progeria syndrome
Other complex diseases may have similar mechanisms, where NETs affect gene localization, causing small changes in the expression of multiple genes, so that pathways are still functioning, but with diminished function, and thus only produce symptoms in some cases
Dr Rafal Czapiewski, lead author and postdoctoral researcher at the Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, said:
"For me, the most interesting part is the discovery of the new mechanism of muscle growth observed in lipodystrophy, which opens up new potential avenues for increasing muscle mass, such as the muscle mass that astronauts lose during space travel , muscular dystrophy or muscle loss from injury
Magazine
Nature Communications
DOI
10.
1038/s41467-021-27869-2